PRISM MEDICO AND PHARMACY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve 1. Consider approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 30th June 2024 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.